Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study
- PMID: 21048986
- PMCID: PMC2964336
- DOI: 10.1371/journal.pmed.1000354
Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study
Erratum in
- PLoS Med. 2011 Feb;8(2). doi: 10.1371/annotation/7e5c299c-2db7-4ddf-8eff-ab793511eccd
Abstract
Background: transparency in reporting of conflict of interest is an increasingly important aspect of publication in medical journals. Publication of large industry-supported trials may generate many citations and journal income through reprint sales and thereby be a source of conflicts of interest for journals. We investigated industry-supported trials' influence on journal impact factors and revenue.
Methods and findings: we sampled six major medical journals (Annals of Internal Medicine, Archives of Internal Medicine, BMJ, JAMA, The Lancet, and New England Journal of Medicine [NEJM]). For each journal, we identified randomised trials published in 1996-1997 and 2005-2006 using PubMed, and categorized the type of financial support. Using Web of Science, we investigated citations of industry-supported trials and the influence on journal impact factors over a ten-year period. We contacted journal editors and retrieved tax information on income from industry sources. The proportion of trials with sole industry support varied between journals, from 7% in BMJ to 32% in NEJM in 2005-2006. Industry-supported trials were more frequently cited than trials with other types of support, and omitting them from the impact factor calculation decreased journal impact factors. The decrease varied considerably between journals, with 1% for BMJ to 15% for NEJM in 2007. For the two journals disclosing data, income from the sales of reprints contributed to 3% and 41% of the total income for BMJ and The Lancet in 2005-2006.
Conclusions: publication of industry-supported trials was associated with an increase in journal impact factors. Sales of reprints may provide a substantial income. We suggest that journals disclose financial information in the same way that they require them from their authors, so that readers can assess the potential effect of different types of papers on journals' revenue and impact.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Medical journals' conflicts of interest in the publication of book reviews.Sci Eng Ethics. 2003 Oct;9(4):471-83. doi: 10.1007/s11948-003-0045-6. Sci Eng Ethics. 2003. PMID: 14652900
-
Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.World J Surg. 2014 Oct;38(10):2487-93. doi: 10.1007/s00268-014-2580-5. World J Surg. 2014. PMID: 24824646
-
How COVID-19 Affected the Journal Impact Factor of High Impact Medical Journals: Bibliometric Analysis.J Med Internet Res. 2022 Dec 21;24(12):e43089. doi: 10.2196/43089. J Med Internet Res. 2022. PMID: 36454727 Free PMC article.
-
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.JAMA. 2011 Mar 9;305(10):1008-17. doi: 10.1001/jama.2011.257. JAMA. 2011. PMID: 21386079 Review.
-
Levels of Influence: Habituation and the Prevalence of Declared Conflicts of Interest.J Bone Joint Surg Am. 2016 Nov 16;98(22):e99. doi: 10.2106/JBJS.16.00474. J Bone Joint Surg Am. 2016. PMID: 27852915 Review.
Cited by
-
The Invisible Hand of Industry.Clin Obstet Gynecol. 2022 Jun 1;65(2):260-267. doi: 10.1097/GRF.0000000000000697. Epub 2022 Feb 28. Clin Obstet Gynecol. 2022. PMID: 35476619 Free PMC article.
-
Reflections after 2 years of COVID-19 pandemic.Rev Med Virol. 2022 Sep;32(5):e2351. doi: 10.1002/rmv.2351. Epub 2022 Apr 5. Rev Med Virol. 2022. PMID: 35384110 Free PMC article. No abstract available.
-
Conflicts of interest: call for new editorial policies in European national journals.Neth Heart J. 2012 Jun;20(6):249-50. doi: 10.1007/s12471-012-0287-5. Neth Heart J. 2012. PMID: 22576787 Free PMC article. No abstract available.
-
Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey.BMC Med Res Methodol. 2020 Oct 19;20(1):260. doi: 10.1186/s12874-020-01144-2. BMC Med Res Methodol. 2020. PMID: 33076823 Free PMC article.
-
Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth.Mens Sana Monogr. 2012 Jan;10(1):158-80. doi: 10.4103/0973-1229.91426. Mens Sana Monogr. 2012. PMID: 22654391 Free PMC article.
References
-
- International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: ethical considerations in the conduct and reporting of research: conflicts of interest. 2010. April 2010. Available: http://www.icmje.org/urm_full.pdf. Accessed 30 August 2010.
-
- Guyatt GH, Naylor D, Richardson WS, Green L, Haynes RB, et al. What is the best evidence for making clinical decisions? JAMA. 2000;284:3127–3128. - PubMed
-
- Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005;2:e138. doi: 10.1371/journal.pmed.0020138. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources